Cancer Detection

Automated tissue dissectors enhance diagnostic precision and help deliver better cancer care 

Inherited genetic determinants can cause normal variations in PSA levels even in the absence of prostate cancer

Pap and HPV testing together is highly sensitive and offers the most comprehensive defense against rising rates of cervical cancer

Complex patterns of mutations and hormonal fluctuations may have key effects on breast cancer etiology

Offering digital cancer risk assessment with point-of-care testing more than doubled the average uptake of genetic testing

Current guidelines ruled 60 percent of individuals identified with HBOC risk as ineligible for genetic testing 

A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse

Updated guidance addresses key questions related to cervical cancer management and introduces lab report templates for clinicians

Predicting the carcinogenicity of tissue-specific driver mutations may help detect and intervene in the early stages of cancer development